Discovery of IDO1 and DNA dual targeting antitumor agents.

about

Discovery of IDO1 and DNA dual targeting antitumor agents.

Item

http://www.wikidata.org/entity/Q48589619

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Discovery of IDO1 and DNA dual targeting antitumor agents.

@en

Discovery of IDO1 and DNA dual targeting antitumor agents.

@nl

type

Item

label

Discovery of IDO1 and DNA dual targeting antitumor agents.

@en

Discovery of IDO1 and DNA dual targeting antitumor agents.

@nl

prefLabel

Discovery of IDO1 and DNA dual targeting antitumor agents.

@en

Discovery of IDO1 and DNA dual targeting antitumor agents.

@nl

P1476

Discovery of IDO1 and DNA dual targeting antitumor agents

@en

P2093

Chunquan Sheng

http://www.w3.org/2001/XMLSchema#string

Guoqiang Dong

http://www.w3.org/2001/XMLSchema#string

Jianhe Liu

http://www.w3.org/2001/XMLSchema#string

Kun Fang

http://www.w3.org/2001/XMLSchema#string

Shanchao Wu

http://www.w3.org/2001/XMLSchema#string

Shuqiang Chen

http://www.w3.org/2001/XMLSchema#string

Ying Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of T cell proliferation by macrophage tryptophan catabolism

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

Research progress of indoleamine 2,3-dioxygenase inhibitors

The future of immune checkpoint therapy

Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses

1-Methyl-DL-tryptophan, beta-(3-benzofuranyl)-DL-alanine (the oxygen analog of tryptophan), and beta-[3-benzo(b)thienyl]-DL-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase

The indoleamine 2,3-dioxygenase pathway controls complement-dependent enhancement of chemo-radiation therapy against murine glioblastoma.

Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy.

Big opportunities for small molecules in immuno-oncology.

Myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: analysis of persistent and new-onset cytopenia

P304

9992-9995

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/C7OB02529G

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Wei Wang

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29177308

http://www.w3.org/2001/XMLSchema#string